Solution: Reimbursement

Insights,

| Stacey Gilbert, MPH, MBA - Director, Precision Medicine

The MolDX Technical Assessment: How to Move Your Test from “Not Successful” to Medicare Coverage Success

Insights,

| Stacey Gilbert, MPH, MBA - Director, Precision Medicine

CRUSH and Genetic and Molecular Laboratories: A Potential Shift in Medicare Oversight

Insights,

| Stacey Gilbert, MPH, MBA - Director, Precision Medicine

March Is Colorectal Cancer Awareness Month: Why CMS’s Proposed NCD 210.3 Update Could Accelerate Patient‑Centered Screening Access

Insights,

| Marc Samuels, JD, MPH - Chief Executive Officer

The 2026 Rare Disease Reality

Insights,

| Stacey Gilbert, MPH, MBA - Director, Precision Medicine

A New Era for Cancer Detection Begins with the Sewell MCED Law

Insights,

| Marc Samuels, JD, MPH - Chief Executive Officer

2026 Life Sciences Forecast: AI, Next-Gen Cell & Gene Therapy, and Policy Disruption

Michael Beebe Shares Insight on Predicted 2025 Developments and Challenges

Evolving Healthcare Landscape: Reimbursement

Insights,

| Melyssa Nocar - Head of Marketing and Communications

What are We Excited to Bring to ADVI Clients in 2024?